| Market Cap | 21.52M 19.27M 17.78M 16.09M 30.09M 2.05B 30.57M 212M 84.62M 1.07B 80.75M 79.03M 3.4B | P/E 2027 * |
-2.3x | P/E 2028 * | 5.91x |
|---|---|---|---|---|---|
| Enterprise Value | 21.52M 19.27M 17.78M 16.09M 30.09M 2.05B 30.57M 212M 84.62M 1.07B 80.75M 79.03M 3.4B | EV / Sales 2027 * |
0.32x | EV / Sales 2028 * | 0.25x |
| Free-Float |
91.84% | Yield 2027 * |
-
| Yield 2028 * | - |
Last Transcript: Aytu Bioscience Inc
| 1 day | +0.47% |
| Manager | Title | Age | Since |
|---|---|---|---|
Jarrett Disbrow
COO | Chief Operating Officer | 50 | 2015-04-15 |
Joshua Disbrow
CEO | Chief Executive Officer | 51 | 2015-04-15 |
Ryan Selhorn
DFI | Director of Finance/CFO | 44 | 2024-11-10 |
| Director | Title | Age | Since |
|---|---|---|---|
Joshua Disbrow
CHM | Chairman | 51 | 2015-04-15 |
Carl Dockery
BRD | Director/Board Member | 63 | 2016-04-12 |
John Donofrio
CHM | Chairman | 59 | 2024-11-05 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| +0.47% | -28.41% | - | - | 21.52M | ||
| +6.63% | +5.13% | +68.86% | +145.20% | 1,224B | ||
| +1.53% | +2.84% | +47.48% | +89.01% | 662B | ||
| +1.68% | +1.96% | +29.16% | +109.31% | 514B | ||
| +0.52% | +3.12% | +54.03% | +67.05% | 388B | ||
| +3.83% | -0.62% | +69.01% | +42.32% | 361B | ||
| +1.01% | +4.22% | +34.91% | +57.63% | 302B | ||
| +3.99% | +5.43% | +7.76% | +32.32% | 271B | ||
| +1.97% | +3.01% | +57.91% | +76.14% | 249B | ||
| +4.03% | +5.36% | +39.76% | +116.14% | 205B | ||
| Average | +1.89% | +2.59% | +45.43% | +81.68% | 464.09B | |
| Weighted average by Cap. | +1.76% | +3.04% | +50.72% | +96.51% |
| 2027 * | 2028 * | |
|---|---|---|
| Net sales | 67.91M 60.83M 56.12M 50.78M 94.96M 6.47B 96.49M 669M 267M 3.38B 255M 249M 10.72B | 86.91M 77.84M 71.82M 64.99M 122M 8.28B 123M 857M 342M 4.33B 326M 319M 13.72B |
| Net income | -11.64M -10.43M -9.62M -8.71M -16.28M -1.11B -16.55M -115M -45.8M -580M -43.7M -42.77M -1.84B | 1.27M 1.14M 1.05M 950K 1.78M 121M 1.81M 12.53M 5M 63.33M 4.77M 4.67M 201M |
| Net Debt | - | - |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
















